Here are relevant reports on : ai-in-personalized-services-market
-
Artificial Intelligence in Retail Market by Solution (Personalized Product Recommendation, Visual Search, Virtual Stores, Virtual Customer Assistant, CRM), Type (Generative AI, Other AI), End-user (Online, Offline) - Global Forecast to 2030
The AI in retail market is projected to reach USD 164.74 billion by 2030, at a CAGR of 32.0% during the forecast period. Microsoft (US), IBM (US), Google (US), Amazon (US), Oracle (US), Salesforce (US), NVIDIA (US), SAP (Germany), ServiceNow (US), Accenture (Ireland), Infosys (India), Alibaba (China), Intel (US), AMD (US), Fujitsu (Japan), Capgemini (France), TCS (India), Talkdesk (US), Symphony AI (US), Bloomreach (US), C3.AI (US), Visenze (Singapore), Pathr.ai (US), Vue.AI (US), Nextail (Spain), Daisy Intelligence (Canada), Cresta (US), Mason (US), Syte (Israel), Trax (Singapore), Feedzai (US), and Shopic (Israel).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) Market by Offering [Hardware (AI Chips, Memory, Storage), Software, Services], Technology (ML, NLP, Generative AI, Neurosymbolic AI), Business Function (Operations & Supply Chain, Sales & Marketing) - Global Forecast to 2033
The Artificial intelligence (AI) market was estimated to be worth USD 601.93 billion in 2026 and is projected to reach USD 3,638.08 billion by 2033, at a CAGR of 29.3%. The major players in the artificial intelligence market include NVIDIA (US), Microsoft (US), Alphabet (US), Amazon Web Services (US), OpenAI (US), Meta (US), IBM (US), Anthropic (US), Cohere (Canada), Mistral AI (France), and Anyscale (US), among others.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031
The global digital twins in healthcare market is projected to reach USD 101.19 billion by 2031, growing at a CAGR of 68.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030
The global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Personalized Nutrition Market by Product (Products, Services, Digital Tools), Application (General Lifestyle, Beauty, Skin & Longevity, Weight Management & Metabolic Health), End-use, Personalization Basis, Type, & Region - Global Forecast to 2030
The personalized nutrition market is estimated to be USD 15.79 billion in 2025 and is projected to reach USD 30.94 billion by 2030, at a CAGR of 14.4% from 2025 to 2030. The report profiles key players such as Abbott (US), Nestlé Health Science (Switzerland), Medtronic (Ireland), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (USA), Nutrigenomix (Canada), Rootine (US), Sun Genomics (US), etc.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping)-Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping) Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Stroke AI Market by Offering (Software, [AI], Services), Classification (ICD, CPT, HCPCS), Specialty (Surgical, Radiology), Function (Code, Assignment, Reimbursement, Analytics, Denial, Audit), End User (Hospital, ASC, Payers) - Global Forecast to 2030
The global stroke AI market, valued at US$0.22 billion in 2024, stood at US$0.32 billion in 2025 and is projected to advance at a resilient CAGR of 38.4% from 2025 to 2030, culminating in a forecasted valuation of US$1.60 billion by the end of the period. The stroke AI market is growing steadily, driven by the need for faster stroke detection, improved clinical decision-making, and reduced time-to-treatment. Increasing adoption of AI-enabled CT and MRI analysis for stroke triage, coupled with rising stroke incidence, aging populations, and hospital digitization, is accelerating demand.
- Published: July 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
